ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,753.01
-0.22%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Myriad Genetics Inc (MYGN)

  7. Myriad Genetics Inc (MYGN) 뉴스

MYGN Myriad Genetics Inc

19.43
0.21 (1.09%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Myriad Genetics Inc MYGN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.21 1.09% 19.43 06:58:41
개장가 저가 고가 종가 전일 종가
19.85 19.40 20.09 19.47 19.22
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202405:05GLOBEMyriad Genetics to Release First Quarter 2024 Financial..
17/04/202421:00GLOBENearly Half of Americans Say They’ve Lost Time in Their..
16/04/202422:15GLOBENew Myriad Genetics Study Published in Prenatal Diagnosis..
09/04/202421:00GLOBEMyriad Genetics Research Shows Reduction in Hospitalizations..
22/03/202410:40GLOBEMyriad Genetics Announces Foundational Patent Granted for..
21/03/202405:05GLOBEMyriad Genetics Announces Patent Granted for SneakPeek® Snap..
05/03/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202422:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/02/202406:05EDGAR2Form 8-K - Current report
28/02/202406:05GLOBEMyriad Genetics Reports Strong Fourth Quarter and Full-Year..
27/02/202423:15GLOBEMyriad Genetics and National Cancer Center Hospital East in..
27/02/202406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202406:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:05GLOBEMyriad Genetics to Release Fourth Quarter and Full Year 2023..
16/02/202406:05GLOBEMyriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as..
15/02/202406:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202422:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/02/202400:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/02/202423:25GLOBEMyriad Genetics Completes Acquisition of Precise Tumor,..
01/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202407:00GLOBEMyriad Genetics Names George Daneker Jr., MD, as President..
30/01/202406:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202406:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/01/202406:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/01/202404:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/01/202408:10GLOBEMyriad Genetics to Acquire Precise Tumor, Precise Liquid and..
16/01/202423:00EDGAR2Form 8-K - Current report
10/01/202406:05GLOBEMyriad Genetics Applauds New Germline Testing Guideline for..
04/01/202406:05GLOBEMyriad Genetics to Present at 42nd Annual J.P. Morgan..
03/01/202407:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:30EDGAR2Form 8-K - Current report
21/12/202322:30GLOBEMyriad Genetics Chief Financial Officer Bryan Riggsbee..
20/12/202322:00GLOBEMyriad Genetics Establishes Comprehensive Pan-Cancer..
12/12/202308:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202308:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/12/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202306:05GLOBEMyriad Genetics Celebrates One Million SneakPeek® Results..
17/11/202306:05GLOBEMyriad Genetics and Personalis Partner to Market..
14/11/202306:31EDGAR2Form 8-K - Current report
13/11/202320:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/11/202321:00GLOBEMyriad Genetics to Participate in Stephens Annual Investment..
09/11/202311:20GLOBEMyriad Genetics Announces Pricing of Upsized Offering of..
09/11/202311:16EDGAR2Form 8-K - Current report
09/11/202306:10GLOBEMyriad Genetics Announces Proposed Offering of $100 Million..
09/11/202306:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/11/202306:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
07/11/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:05EDGAR2Form 8-K - Current report
07/11/202306:05GLOBEMyriad Genetics Reports Third Quarter 2023 Financial..
04/11/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
MYGN
Myriad Genetics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유